Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Wießner

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Psychopharmacology|October 28, 2021
Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flowIsabel Wießner, Marcelo Falchi, Fernanda Palhano-Fontes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 20, 2023
LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individualsIsabel Wießner, Marcelo Falchi, Dimitri Daldegan-Bueno, et al.
Journal of Psychopharmacology (Oxford, England)|February 2, 2022
LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinkingIsabel Wießner, Marcelo Falchi, Lucas Oliveira Maia, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2023
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trialMarcelo Falchi-Carvalho, Isabel Wießner, Sérgio Ruschi B Silva, et al.
Experimental Neurology|June 22, 2022
Nootropic effects of LSD: Behavioral, molecular and computational evidenceIsis M Ornelas, Felipe A Cini, Isabel Wießner, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|May 8, 2025
The Antidepressant Effects of Vaporized <i>N</i>,<i>N</i>-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant DepressionMarcelo Falchi-Carvalho, Handersson Barros, Raynara Bolcont, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 18, 2025
Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trialIsabel Wießner, Marcelo Falchi-Carvalho, Sophie Laborde, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 21, 2025
Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depressionMarcelo Falchi-Carvalho, Fernanda Palhano-Fontes, Isabel Wießner, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Psychopharmacology|October 28, 2021
Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flowIsabel Wießner, Marcelo Falchi, Fernanda Palhano-Fontes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 20, 2023
LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individualsIsabel Wießner, Marcelo Falchi, Dimitri Daldegan-Bueno, et al.
Journal of Psychopharmacology (Oxford, England)|February 2, 2022
LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinkingIsabel Wießner, Marcelo Falchi, Lucas Oliveira Maia, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 23, 2023
Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trialMarcelo Falchi-Carvalho, Isabel Wießner, Sérgio Ruschi B Silva, et al.
Experimental Neurology|June 22, 2022
Nootropic effects of LSD: Behavioral, molecular and computational evidenceIsis M Ornelas, Felipe A Cini, Isabel Wießner, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|May 8, 2025
The Antidepressant Effects of Vaporized <i>N</i>,<i>N</i>-Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant DepressionMarcelo Falchi-Carvalho, Handersson Barros, Raynara Bolcont, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 18, 2025
Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trialIsabel Wießner, Marcelo Falchi-Carvalho, Sophie Laborde, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 21, 2025
Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depressionMarcelo Falchi-Carvalho, Fernanda Palhano-Fontes, Isabel Wießner, et al.
Pageof 2